Overview
Radhika Kainthla is a Hematologist and an Oncologist in Dallas, Texas. Dr. Kainthla is rated as an Experienced provider by MediFind in the treatment of Shwartzman Phenomenon. Her top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Aspiration.
Her clinical research consists of co-authoring 25 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5303 Harry Hines Blvd, Dallas, TX 75390
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Texas Southwestern Medical Center At Dallas
Ibrahim Ibrahim is a Hematologist Oncology specialist and a Hematologist in Dallas, Texas. Dr. Ibrahim is rated as a Distinguished provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Essential Thrombocythemia, Shwartzman Phenomenon, Venous Thromboembolism (VTE), Hereditary Hemorrhagic Telangiectasia, and Bone Marrow Aspiration.
University Of Texas Southwestern Medical Center At Dallas
Taha Bat is a Hematologist and an Oncologist in Dallas, Texas. Dr. Bat is rated as a Distinguished provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Acute Hepatic Porphyria (AHP), and Porphyria.
University Of Texas Southwestern Medical Center At Dallas
John Hancock is a Hematologist Oncology specialist and a Hematologist in Dallas, Texas. Dr. Hancock is rated as an Advanced provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Prothrombin Deficiency, Shwartzman Phenomenon, Venous Thromboembolism (VTE), Endoscopy, and Stent Placement. Dr. Hancock is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Colorectal CancerDr. Kainthla isDistinguished. Learn about Familial Colorectal Cancer.
- Advanced
- Colorectal CancerDr. Kainthla isAdvanced. Learn about Colorectal Cancer.
- Lynch SyndromeDr. Kainthla isAdvanced. Learn about Lynch Syndrome.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Kainthla isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Dr. Kainthla isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myeloblastic Leukemia with MaturationDr. Kainthla isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Kainthla isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaDr. Kainthla isExperienced. Learn about Acute Promyelocytic Leukemia.